Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40132747.
- Also identified by DOI 10.1016/j.jpeds.2025.114564 and PMC identifier 12184987.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study analyzed adolescent metabolic and bariatric surgery (MBS) utilization before and after glucagon-like peptide-1 receptor agonist (GLP-1RA) medication approval, comparing trends across race and ethnic groups. Although both MBS and GLP-1RA are effective weight management strategies, adolescent MBS utilization increased, while adult rates declined from 2021 through 2023.
Medical subject headings
- Bariatric Surgery
- Glucagon-Like Peptide-1 Receptor Agonists
- Diabetes Mellitus, Type 2